Measurement of oral chronic GVHD: Results from the Chronic GVHD Consortium

Bone Marrow Transplantation

Volumn 48, Issue 8, 2013, Pages 1123-1128

  Treister, N ^a   Chai, X ^b   Kurland, B ^b   Pavletic, S ^c   Weisdorf, D ^d   Pidala, J ^e   Palmer, J ^f   Martin, P ^b   Inamoto, Y ^b   Arora, M ^d   Flowers, M ^b   Jacobsohn, D ^g   Jagasia, M ^h   Arai, S ⁱ   Lee, S J ^b   Cutler, C ^j  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^e H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^f MEDICAL COLLEGE OF WISCONSIN   (United States)

^g CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^h VANDERBILT INGRAM CANCER CENTER   (United States)

ⁱ STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j DANA FARBER CANCER INSTITUTE   (United States)

more..

Author keywords

GVHD; Oral cavity; Quality of life; SCT

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; ERYTHEMA; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; LICHENOID; MAJOR CLINICAL STUDY; MALE; MOUTH DISEASE; MOUTH EXAMINATION; MULTICENTER STUDY; NATIONAL HEALTH ORGANIZATION; OBSERVATIONAL STUDY; PATIENT ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RATING SCALE; SCHOOL CHILD; SYMPTOMATOLOGY;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; COHORT STUDIES; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MOUTH DISEASES; NATIONAL INSTITUTES OF HEALTH (U.S.); PROSPECTIVE STUDIES; QUALITY OF LIFE; UNITED STATES; YOUNG ADULT;

EID: 84881378185     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2012.285     Document Type: Article

References (27)

1. Lee SJ, Vogelsang G, Flowers ME. Chronic graft-versus-host disease. Biol Blood Marrow Transplant 2003; 9: 215-233
2. Arai S, Jagasia M, Storer B, Chai X, Pidala J, Cutler C et al. Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria. Blood 2011; 118: 4242-4249
3. Flowers ME, Parker PM, Johnston LJ, Matos AV, Storer B, Bensinger WI et al. Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: Long-Term follow-up of a randomized trial. Blood 2002; 100: 415-419
4. Imanguli MM, Alevizos I, Brown R, Pavletic SZ, Atkinson JC. Oral graft-versus-host disease. Oral Dis 2008; 14: 396-412
5. Schubert MM, Correa ME. Oral graft-versus-host disease. Dent Clin North Am 2008; 52: 79-109viii-ix.
6. Couriel D, Carpenter PA, Cutler C, Bolanos-Meade J, Treister NS, Gea-Banacloche J et al. Ancillary therapy and supportive care of chronic graft-versus-host disease: National institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report. Biol Blood Marrow Transplant 2006; 12: 375-396
7. Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945-956
8. Martin PJ, Weisdorf D, Przepiorka D, Hirschfeld S, Farrell A, Rizzo JD et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. Design of Clinical Trials Working Group report. Biol Blood Marrow Transplant 2006; 12: 491-505
9. Pavletic SZ, Martin P, Lee SJ, Mitchell S, Jacobsohn D, Cowen EW et al. Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report. Biol Blood Marrow Transplant 2006; 12: 252-266
10. Rationale and design of the chronic GVHD cohort study: Improving outcomes assessment in chronic GVHD. Biol Blood Marrow Transplant 2011; 17: 1114-1120
11. Jacobsohn DA, Chen AR, Zahurak M, Piantadosi S, Anders V, Bolanos-Meade J et al. Phase II study of pentostatin in patients with corticosteroid-refractory chronic graft-versus-host disease. J Clin Oncol 2007; 25: 4255-4261
12. Lee S, Cook EF, Soiffer R, Antin JH. Development and validation of a scale to measure symptoms of chronic graft-versus-host disease. Biol Blood Marrow Transplant 2002; 8: 444-452
13. Fleiss J, Cohen J. The equivalence of weighted kappa and the intraclass correlation coefficient as measures of reliability. Educ Psychol Meas 1973; 33: 613-619
14. Gardiner JC, Luo Z, Roman LA. Fixed effects, random effects and GEE: What are the differences? Stat Med 2009; 28: 221-239
15. Fitzmaurice GMLN, Ware JH. Applied longitudinal analysis. 2nd edn (Wiley: Hoboken, 2011
16. Laird NM. Missing data in longitudinal studies. Stat Med 1988; 7: 305-315
17. Pavletic SZ, Lee SJ, Socie G, Vogelsang G. Chronic graft-versus-host disease: Implications of the National Institutes of Health consensus development project on criteria for clinical trials. Bone Marrow Transplant 2006; 38: 645-651
18. Palmer JM, Lee SJ, Chai X, Storer BE, Flowers ME, Schultz KR et al. Poor agreement between clinician response ratings and calculated response measures in patients with chronic graft-versus-host disease. Biol Blood Marrow Transplant 2012; 18: 1649-1655
19. Treister NS, Stevenson K, Kim H, Woo SB, Soiffer R, Cutler C. Oral chronic graftversus-host disease scoring using the NIH consensus criteria. Biol Blood Marrow Transplant 2009; 16: 108-114
20. Mitchell SA, Jacobsohn D, Thormann Powers KE, Carpenter PA, Flowers ME, Cowen EW et al. A multicenter pilot evaluation of the National Institutes of Health chronic graft-versus-host disease (cGVHD) therapeutic response measures: Feasibility, interrater reliability, and minimum detectable change. Biol Blood Marrow Transplant 2011; 17: 1619-1629
21. Elad S, Zeevi I, Or R, Resnick IB, Dray L, Shapira MY. Validation of the National Institutes of Health (NIH) scale for oral chronic graft-versus-host disease (cGVHD). Biol Blood Marrow Transplant 2009; 16: 62-69
22. Treister NS, Cook Jr. EF, Antin J, Lee SJ, Soiffer R, Woo SB. Clinical evaluation of oral chronic graft-versus-host disease. Biol Blood Marrow Transplant 2008; 14: 110-115
23. Treister NS, Stevenson K, Kim H, Woo SB, Soiffer R, Cutler C. Oral chronic graftversus-host disease scoring using the NIH consensus criteria. Biol Blood Marrow Transplant 2010; 16: 108-114
24. Castellarin P, Stevenson K, Biasotto M, Yuan A, Woo SB, Treister NS. Extensive dental caries in patients with oral chronic graft-versus-host disease. Biol Blood Marrow Transplant 2012; 18: 1573-1579
25. Pidala J, Kurland B, Chai X, Majhail N, Weisdorf DJ, Pavletic S et al. Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: Report on baseline data from the Chronic GVHD Consortium. Blood 2011; 117: 4651-4657
26. Pidala J, Kurland BF, Chai X, Vogelsang G, Weisdorf DJ, Pavletic S et al. Sensitivity of changes in chronic graft-versus-host disease activity to changes in patientreported quality of life: Results from the Chronic Graft-versus-Host Disease Consortium. Haematologica 2011; 96: 1528-1535
27. Inamoto Y, Martin PJ, Chai X, Jagasia M, Palmer J, Pidala J et al. Clinical benefit of response in chronic graft-versus-host disease. Biol Blood Marrow Transplant 2012; 18: 1517-1524